The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.

Métral, M; Darling, Kea; Locatelli, I; Nadin, I; Santos, G; Brugger, P; Kovari, H; Cusini, Alexia; Gutbrod, Klemens; Tarr, P E; Calmy, A; Lecompte, T D; Assal, F; Monsch, A; Kunze, U; Stoeckle, M; Schwind, M; Schmid, P; Pignatti, R; Di Benedetto, C; ... (2020). The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile. HIV medicine, 21(1), pp. 30-42. Wiley 10.1111/hiv.12795

[img]
Preview
Text
M-tral_et_al-2019-HIV_Medicine (1).pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (229kB) | Preview

OBJECTIVES The aim of the study was to examine baseline neurocognitive impairment (NCI) prevalence and factors associated with NCI among patients enrolled in the Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study. METHODS The NAMACO study is an ongoing, prospective, longitudinal, multicentre and multilingual (German, French and Italian) study within the Swiss HIV Cohort Study. Between 1 May 2013 and 30 November 2016, 981 patients ≥ 45 years old were enrolled in the study. All underwent standardized neuropsychological (NP) assessment by neuropsychologists. NCI was diagnosed using Frascati criteria and classified as HIV-associated or as related to other factors. Dichotomized analysis (NCI versus no NCI) and continuous analyses (based on NP test z-score means) were performed. RESULTS Most patients (942; 96.2%) had viral loads < 50 HIV-1 RNA copies/mL. NCI was identified in 390 patients (39.8%): 263 patients (26.8%) had HIV-associated NCI [249 patients (25.4%) had asymptomatic neurocognitive impairment (ANI)] and 127 patients (13%) had NCI attributable to other factors, mainly psychiatric disorders. There was good correlation between dichotomized and continuous analyses, with NCI associated with older age, non-Caucasian ethnicity, shorter duration of education, unemployment and longer antiretroviral therapy duration. CONCLUSIONS In this large sample of aging people living with HIV with well-controlled infection in Switzerland, baseline HIV-associated NCI prevalence, as diagnosed after formal NP assessment, was 26.8%, with most cases being ANI. The NAMACO study data will enable longitudinal analyses within this population to examine factors affecting NCI development and course.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Cusini, Alexia and Gutbrod, Klemens

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1464-2662

Publisher:

Wiley

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

24 Oct 2019 14:43

Last Modified:

13 Dec 2019 01:31

Publisher DOI:

10.1111/hiv.12795

PubMed ID:

31589807

Uncontrolled Keywords:

HIV-associated neurocognitive disorder aging neurocognitive impairment neuropsychological testing

BORIS DOI:

10.7892/boris.133878

URI:

https://boris.unibe.ch/id/eprint/133878

Actions (login required)

Edit item Edit item
Provide Feedback